PLA2G4B and colorectal carcinoma: To explore whether FASN contributes to CRC cell malignant phenotypes and PC metabolism via PLA2G4B, PLA2G4B expression was silenced in HCT-116 and RKO cells using three commercial PLA2G4B siRNAs.